Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Non-Current Deferred Tax Liability (2018 - 2025)

Historic Non-Current Deferred Tax Liability for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to $2.4 million.

  • Revolution Medicines' Non-Current Deferred Tax Liability fell 2446.23% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 2446.23%. This contributed to the annual value of $2.4 million for FY2024, which is 2446.23% down from last year.
  • Revolution Medicines' Non-Current Deferred Tax Liability amounted to $2.4 million in Q3 2025, which was down 2446.23% from $2.4 million recorded in Q2 2025.
  • Revolution Medicines' 5-year Non-Current Deferred Tax Liability high stood at $7.4 million for Q1 2021, and its period low was $2.4 million during Q4 2024.
  • In the last 5 years, Revolution Medicines' Non-Current Deferred Tax Liability had a median value of $7.0 million in 2022 and averaged $5.2 million.
  • As far as peak fluctuations go, Revolution Medicines' Non-Current Deferred Tax Liability surged by 506.7% in 2021, and later plummeted by 5581.98% in 2023.
  • Revolution Medicines' Non-Current Deferred Tax Liability (Quarter) stood at $7.4 million in 2021, then dropped by 5.63% to $7.0 million in 2022, then plummeted by 55.66% to $3.1 million in 2023, then decreased by 24.46% to $2.4 million in 2024, then changed by 0.0% to $2.4 million in 2025.
  • Its Non-Current Deferred Tax Liability was $2.4 million in Q3 2025, compared to $2.4 million in Q2 2025 and $2.4 million in Q1 2025.